Micronics will be a wholly owned subsidiary of SCA, and will work with the relevant division, including Sony's life sciences R & D team, to develop jointly technologies and new products. The company will continue to operate in Redmond under the current Micronics management team, headed by company President Karen Hedine.

Engaged in the research and development of near patient Point of Care (POC) devices for disease diagnosis, treatment monitoring, and blood testing, Micronics also provides comprehensive product development for third-party clients. The company's main focus in recent years has been its molecular diagnostic platform for the diagnosis of infectious disease.

Mr. Keiji Kimura, EVP and Executive Officer, Sony Corporation, commented, "For some time, Sony has applied its consumer electronics technology to contribute to research and development in the medical and healthcare fields. We believe that the combination of Micronics' development capabilities in the medical diagnosis domain and our consumer electronics and IT technologies, such as in optical discs, will enable us to offer innovative solutions that are responsive to the rapidly escalating needs for Point of Care diagnosis worldwide."

Related Links:
Sony Corp.
Sony Corporation of America
Micronics, Inc.